1359 related articles for article (PubMed ID: 32894072)
1. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
[TBL] [Abstract][Full Text] [Related]
2. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of on-site rapid HIV/HBV/HCV testing and HBV vaccination among three at-risk populations in distinct community-healthcare outreach centres: the ANRS-SHS 154 CUBE study.
Calin R; Massari V; Pialoux G; Reydellet N; Plenel E; Chauvin C; Jauffret-Roustide M; Day N; Kreplak G; Maresca AF; Derche N; Louis S; Pol S; Doré V; Rouzioux C; Chauvin P
BMC Infect Dis; 2020 Nov; 20(1):851. PubMed ID: 33198672
[TBL] [Abstract][Full Text] [Related]
4. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa.
Barth RE; Huijgen Q; Tempelman HA; Mudrikova T; Wensing AM; Hoepelman AI
J Med Virol; 2011 Jun; 83(6):929-34. PubMed ID: 21503902
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
[TBL] [Abstract][Full Text] [Related]
7. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
[TBL] [Abstract][Full Text] [Related]
8. Sexual behaviors and seroprevalence of HIV, HBV, and HCV among hill tribe youths of Northern Thailand.
Apidechkul T
BMC Public Health; 2019 Aug; 19(1):1101. PubMed ID: 31412838
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus and hepatitis C virus infections among female sex workers and men who have sex with men in Lebanon: prevalence, risk behaviour and immune status.
Kassak K; Mahfoud Z; Kreidieh K; Shamra S; Afifi R; Ramia S
Sex Health; 2011 Jun; 8(2):229-33. PubMed ID: 21592438
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
11. A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?
Leung J; Peacock A; Colledge S; Grebely J; Cunningham EB; Hickman M; Vickerman P; Stone J; Trickey A; Dumchev K; Lynskey M; Hines L; Griffiths P; Mattick RP; Degenhardt L; Larney S
J Infect Dis; 2019 Jun; 220(1):78-90. PubMed ID: 30726973
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.
el-Sayed NM; Gomatos PJ; Rodier GR; Wierzba TF; Darwish A; Khashaba S; Arthur RR
Am J Trop Med Hyg; 1996 Aug; 55(2):179-84. PubMed ID: 8780457
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis C infection, screening and associated factors among men who have sex with men attending gay venues: a cross-sectional survey (PREVAGAY), France, 2015.
Vaux S; Chevaliez S; Saboni L; Sauvage C; Sommen C; Barin F; Alexandre A; Jauffret-Roustide M; Lot F; Velter A;
BMC Infect Dis; 2019 Apr; 19(1):315. PubMed ID: 30971207
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.
Bhattarai M; Baniya JB; Aryal N; Shrestha B; Rauniyar R; Adhikari A; Koirala P; Oli PK; Pandit RD; Stein DA; Gupta BP
Biomed Res Int; 2018; 2018():9241679. PubMed ID: 29487874
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of HCV, HBV and HIV in two inner-city London emergency departments.
Cieply L; Simmons R; Ijaz S; Kara E; Rodger A; Rosenberg W; McGuinness A; Mbisa JL; Ledesma J; Ohemeng-Kumi N; Dicks S; Potts H; Lattimore S; Mandal S
Epidemiol Infect; 2019 Jan; 147():e145. PubMed ID: 30869036
[TBL] [Abstract][Full Text] [Related]
16. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.
Khatib A; Matiko E; Khalid F; Welty S; Ali A; Othman A; Haji S; Dahoma M; Rutherford G
BMC Public Health; 2017 Nov; 17(1):917. PubMed ID: 29183287
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors associated with HIV and tuberculosis in people who use drugs in Abidjan, Ivory Coast.
Bouscaillou J; Evanno J; Prouté M; Inwoley A; Kabran M; N'Guessan T; Djé-Bi S; Sidibé S; Thiam-Niangoin M; N'guessan BR; Blanchetière P; Luhmann N
Int J Drug Policy; 2016 Apr; 30():116-23. PubMed ID: 26964902
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of viral hepatitis B and C in men who have sex with men enrolled in a demonstration study of pre-exposure prophylaxis for HIV in Cotonou, Benin].
Béhanzin L; Diabaté S; Guédou FA; Matsétsé EG; Olodo M; Dossouvo A; Aza-Gnandji M; Akpaka A; Chagas E; Gangbo F; Zannou DM; Alary M
Pan Afr Med J; 2023; 46():79. PubMed ID: 38282778
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of HIV, viral hepatitis B/C and tuberculosis and treatment outcomes among people who use drugs: Results from the implementation of the first drop-in-center in Mozambique.
Semá Baltazar C; Kellogg TA; Boothe M; Loarec A; de Abreu E; Condula M; Fazito E; Raymond HF; Temmerman M; Luchters S
Int J Drug Policy; 2021 Apr; 90():103095. PubMed ID: 33429163
[TBL] [Abstract][Full Text] [Related]
20. HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.
Ray Saraswati L; Sarna A; Sebastian MP; Sharma V; Madan I; Thior I; Pulerwitz J; Tun W
BMC Public Health; 2015 Jul; 15():726. PubMed ID: 26223866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
